Skip to main content
NIH funding notice RFA-MH-22-106

Expanding Differentiated Care Approaches for Adolescents Living with HIV (R34 Clinical Trial Optional)

Closed on January 6, 2022.

Posted
October 20, 2021
Close date
January 6, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $182,054 in first-year total cost, median $182,054.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 RPHB-M (53)]1

Most frequent institutions

  1. JOHNS HOPKINS UNIVERSITY1
Competing awards under RFA-MH-22-106 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Designing Next Generation Treatment Strategies for Adolescents and Young Adults Living with HIV (The NextGen Study)1R34MH131429-01ORRELL, CATHERINESCHWARTZ, SHEREE RENAEJOHNS HOPKINS UNIVERSITY, MD$182,054ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-MH-22-106: Expanding Differentiated Care Approaches for Adolescents Living with HIV (R34 Clinical Trial Optional) | ScienceDex | ConductScience